| |
| |
|
| Insider
Information: |
Lynch Samuel Eugene |
| Relationship: |
Director |
| City: |
Frankling |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
491 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
491 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomimetic Therapeutics, Inc. |
BMTI |
President and CEO, Dir... |
2013-03-01 |
0 |
2013-03-01 |
0 |
Premium* |
|
|
Capital Bank Financial Corp. |
CBF |
Director |
2012-10-01 |
491 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,392,923) |
0 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2013-03-01 |
4 |
D |
$9.07 |
$704,336 |
D/D |
(77,623) |
1,392,923 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2013-03-01 |
4 |
OE |
$2.08 |
$530,570 |
D/D |
221,000 |
1,470,546 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,550) |
0 |
0 |
- |
|
| CBF |
Capital Bank Financial Co... |
Director |
– • – |
2012-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
491 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-30 |
4 |
B |
$2.40 |
$95,632 |
D/D |
39,362 |
1,239,391 |
2.81 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-29 |
4 |
B |
$2.38 |
$72,891 |
D/D |
30,638 |
1,200,029 |
2.81 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-23 |
4 |
B |
$2.35 |
$1,058 |
I/I |
450 |
5,550 |
2.58 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-23 |
4 |
B |
$2.35 |
$29,845 |
D/D |
12,700 |
1,169,391 |
2.81 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-20 |
4 |
GA |
$0.00 |
$0 |
D/D |
100,000 |
1,114,422 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
42,269 |
1,156,691 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
42,269 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2012-03-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(42,269) |
0 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2011-11-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
112,072 |
142,269 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2011-11-16 |
4 |
GA |
$0.00 |
$0 |
D/D |
112,072 |
1,014,422 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2011-05-18 |
4 |
B |
$7.75 |
$102,250 |
D/D |
13,000 |
898,912 |
2.81 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
100,000 |
254,341 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
882,220 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
50 |
154,341 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-31 |
4 |
GA |
$0.00 |
$0 |
D/D |
50 |
982,220 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-30 |
4 |
OE |
$3.63 |
$95,288 |
D/D |
26,250 |
982,170 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-29 |
4 |
GA |
$0.00 |
$0 |
D/D |
15,100 |
955,920 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-12-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,100 |
154,391 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-09-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
102,130 |
169,491 |
0 |
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
President and CEO |
• • – |
2010-09-09 |
4 |
GA |
$0.00 |
$0 |
D/D |
102,130 |
940,820 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
